skip to main content
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Medline Complete remover tipo de recurso: Anais de Congresso remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
BIIB059, a Humanized Monoclonal Antibody Targeting Blood Dendritic Cell Antigen 2 on Plasmacytoid Dendritic Cells, Shows Dose-Related Efficacy in a Phase 2 Study in Participants with Active Cutaneous Lupus Erythematosus
Material Type:
Ata de Congresso
Adicionar ao Meu Espaço

BIIB059, a Humanized Monoclonal Antibody Targeting Blood Dendritic Cell Antigen 2 on Plasmacytoid Dendritic Cells, Shows Dose-Related Efficacy in a Phase 2 Study in Participants with Active Cutaneous Lupus Erythematosus

Werth, V ; Furie, R ; Romero-Diaz, J ; Navarra, S ; Kalunian, K ; van Vollenhoven, R ; Nyberg, F ; Kaffenberger, B ; Sheikh, S ; Radunovic, G ; Huang, XB ; Carroll, H ; Gaudreault, F ; Meyers, A ; Barbey, C ; Musselli, C ; Franchimont, N

ARTHRITIS & RHEUMATOLOGY, 2020, Vol.72 [Periódico revisado por pares]

Texto completo disponível

2
Safety Profile of Belimumab, a B-Lymphocyte Stimulator-Specific Inhibitor, in Phase 2 and 3 Clinical Trials of Patients with Active Systemic Lupus Erythematosus
Material Type:
Ata de Congresso
Adicionar ao Meu Espaço

Safety Profile of Belimumab, a B-Lymphocyte Stimulator-Specific Inhibitor, in Phase 2 and 3 Clinical Trials of Patients with Active Systemic Lupus Erythematosus

Wallace, DJ ; Navarra, S ; Petri, M ; Gallacher, A ; Guzman, R ; Thomas, M ; Furie, RA ; Zamani, O ; Levy, RA ; van Vollenhoven, RF ; Cooper, S ; Zhong, ZJ ; Freimuth, W ; Pineda, L ; Cervera, R

ARTHRITIS AND RHEUMATISM, 2011, Vol.63 (10), p.S220

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1)

Refinar Meus Resultados

Data de Publicação 

De até

Buscando em bases de dados remotas. Favor aguardar.